Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karlyne M Reilly

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Neuro-Oncology|January 12, 2012
Arlm1 is a male-specific modifier of astrocytoma resistance on mouse Chr 12Jessica C Amlin-Van Schaick, Sungjin Kim, Christina DiFabio, et al.
Epigenetics|January 12, 2008
Real-time PCR analysis of candidate imprinted genes on mouse chromosome 11 shows balanced expression from the maternal and paternal chromosomes and strain-specific variation in expression levelsRobert G Tuskan, Shirley Tsang, Zhonghe Sun, et al.
Cancer Research|October 23, 2014
Cellular factors promoting resistance to effective treatment of glioma with oncolytic myxoma virusFranz J Zemp, Brienne A McKenzie, Xueqing Lun, et al.
Journal of Translational Medicine|November 26, 2004
Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumorsManabu Hatano, Naruo Kuwashima, Tomohide Tatsumi, et al.
Plos One|June 14, 2013
Resistance to oncolytic myxoma virus therapy in nf1(-/-)/trp53(-/-) syngeneic mouse glioma models is independent of anti-viral type-I interferonFranz J Zemp, Brienne A McKenzie, Xueqing Lun, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 16, 2025
Investigating fatigue in adults with neuroendocrine neoplasms using a biopsychosocial modelSarah W Peters, Pamela L Wolters, Jaydira Del Rivero, et al.
Frontiers in Endocrinology|November 17, 2022
Pediatric adrenocortical carcinomaMaran Ilanchezhian, Diana Grace Varghese, John W Glod, et al.
Endocrinology, Diabetes & Metabolism Case Reports|January 10, 2020
Adrenocortical carcinoma masquerading as pheochromocytoma: a histopathologic dilemmaImpana Shetty, Sarah Fuller, Margarita Raygada, et al.
Journal of Natural Products|October 16, 2015
Deguelins, Natural Product Modulators of NF1-Defective Astrocytoma Cell Growth Identified by High-Throughput Screening of Partially Purified Natural Product ExtractsCurtis J Henrich, Laura K Cartner, Jennifer A Wilson, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|February 12, 2014
Quantitative analysis of F-actin redistribution in astrocytoma cells treated with candidate pharmaceuticalsStephen Lockett, Chrissie Verma, Alla Brafman, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Neuro-Oncology|January 12, 2012
Arlm1 is a male-specific modifier of astrocytoma resistance on mouse Chr 12Jessica C Amlin-Van Schaick, Sungjin Kim, Christina DiFabio, et al.
Epigenetics|January 12, 2008
Real-time PCR analysis of candidate imprinted genes on mouse chromosome 11 shows balanced expression from the maternal and paternal chromosomes and strain-specific variation in expression levelsRobert G Tuskan, Shirley Tsang, Zhonghe Sun, et al.
Cancer Research|October 23, 2014
Cellular factors promoting resistance to effective treatment of glioma with oncolytic myxoma virusFranz J Zemp, Brienne A McKenzie, Xueqing Lun, et al.
Journal of Translational Medicine|November 26, 2004
Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumorsManabu Hatano, Naruo Kuwashima, Tomohide Tatsumi, et al.
Plos One|June 14, 2013
Resistance to oncolytic myxoma virus therapy in nf1(-/-)/trp53(-/-) syngeneic mouse glioma models is independent of anti-viral type-I interferonFranz J Zemp, Brienne A McKenzie, Xueqing Lun, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 16, 2025
Investigating fatigue in adults with neuroendocrine neoplasms using a biopsychosocial modelSarah W Peters, Pamela L Wolters, Jaydira Del Rivero, et al.
Frontiers in Endocrinology|November 17, 2022
Pediatric adrenocortical carcinomaMaran Ilanchezhian, Diana Grace Varghese, John W Glod, et al.
Endocrinology, Diabetes & Metabolism Case Reports|January 10, 2020
Adrenocortical carcinoma masquerading as pheochromocytoma: a histopathologic dilemmaImpana Shetty, Sarah Fuller, Margarita Raygada, et al.
Journal of Natural Products|October 16, 2015
Deguelins, Natural Product Modulators of NF1-Defective Astrocytoma Cell Growth Identified by High-Throughput Screening of Partially Purified Natural Product ExtractsCurtis J Henrich, Laura K Cartner, Jennifer A Wilson, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|February 12, 2014
Quantitative analysis of F-actin redistribution in astrocytoma cells treated with candidate pharmaceuticalsStephen Lockett, Chrissie Verma, Alla Brafman, et al.
Pageof 6